6.40
price down icon1.08%   -0.07
after-market Dopo l'orario di chiusura: 6.40
loading
Precedente Chiudi:
$6.47
Aprire:
$6.45
Volume 24 ore:
322.24K
Relative Volume:
0.76
Capitalizzazione di mercato:
$424.69M
Reddito:
$555.06M
Utile/perdita netta:
$-39.48M
Rapporto P/E:
-10.67
EPS:
-0.6
Flusso di cassa netto:
$29.05M
1 W Prestazione:
-1.39%
1M Prestazione:
-5.33%
6M Prestazione:
-36.19%
1 anno Prestazione:
-14.21%
Intervallo 1D:
Value
$6.37
$6.505
Intervallo di 1 settimana:
Value
$6.26
$6.59
Portata 52W:
Value
$6.02
$14.38

Bioventus Inc Stock (BVS) Company Profile

Name
Nome
Bioventus Inc
Name
Telefono
(919) 474-6700
Name
Indirizzo
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Name
Dipendente
930
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
BVS's Discussions on Twitter

Confronta BVS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
BVS
Bioventus Inc
6.40 427.34M 555.06M -39.48M 29.05M -0.60
Medical Devices icon
ABT
Abbott Laboratories
125.64 218.92B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.21 152.62B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
396.66 153.22B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.32 117.89B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
75.80 45.12B 5.54B 4.18B 623.10M 7.00

Bioventus Inc Stock (BVS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-07 Iniziato Cantor Fitzgerald Overweight
2024-12-17 Aggiornamento JP Morgan Underweight → Neutral
2023-12-07 Aggiornamento Canaccord Genuity Hold → Buy
2023-08-09 Aggiornamento Craig Hallum Hold → Buy
2022-11-22 Downgrade Craig Hallum Buy → Hold
2022-11-09 Downgrade Canaccord Genuity Buy → Hold
2022-11-09 Downgrade JP Morgan Overweight → Underweight
2022-03-15 Iniziato Craig Hallum Buy
2021-11-15 Ripresa Morgan Stanley Overweight
2021-11-10 Ripresa JP Morgan Overweight
2021-07-01 Downgrade Goldman Buy → Neutral
2021-03-08 Iniziato Canaccord Genuity Buy
2021-03-08 Iniziato Goldman Buy
2021-03-08 Iniziato JP Morgan Overweight
2021-03-08 Iniziato Morgan Stanley Overweight
Mostra tutto

Bioventus Inc Borsa (BVS) Ultime notizie

pulisher
Jul 23, 2025

Is Bioventus Inc. a good long term investmentHigh-octane gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Bioventus Inc. Stock Analysis and ForecastExplosive earning power - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Bioventus Inc. stockExplosive market performance - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Bioventus Inc. stock priceAccelerated wealth building - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Bioventus (NASDAQ:BVS) Cut to “Buy” at Wall Street Zen - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

Cantor Fitzgerald Initiates Coverage of Bioventus (BVS) with an Overweight Rating - MSN

Jul 20, 2025
pulisher
Jul 18, 2025

Bioventus (NASDAQ:BVS) Downgraded to Buy Rating by Wall Street Zen - MarketBeat

Jul 18, 2025
pulisher
Jul 18, 2025

Analysts Expect Bioventus Inc. (NASDAQ:BVS) To Breakeven Soon - simplywall.st

Jul 18, 2025
pulisher
Jul 17, 2025

What makes Bioventus Inc. stock price move sharplyFree Best Performing Stock Alerts - beatles.ru

Jul 17, 2025
pulisher
Jul 17, 2025

why bioventus inc. stock attracts strong analyst attentionWeekly Big Movers - newser.com

Jul 17, 2025
pulisher
Jul 16, 2025

How Bioventus Inc. stock performs during market volatilityBreakout Momentum Stocks - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

Why Bioventus Inc. stock attracts strong analyst attentionFree Stock Market Strategy Classes - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

10 Undervalued Medical Device Stocks to Buy Now - Insider Monkey

Jul 15, 2025
pulisher
Jul 11, 2025

Allspring Global Investments Holdings LLC Raises Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World

Jul 11, 2025
pulisher
Jul 10, 2025

With 36% stake, Bioventus Inc. (NASDAQ:BVS) seems to have captured institutional investors' interest - Yahoo Finance

Jul 10, 2025
pulisher
Jul 09, 2025

How the (BVS) price action is used to our Advantage - news.stocktradersdaily.com

Jul 09, 2025
pulisher
Jul 09, 2025

Bioventus(BVS) Shares Soar 3.54% on Pipeline Progress - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Cantor Fitzgerald Initiates Coverage on Bioventus (NYSE:BVS) - Defense World

Jul 09, 2025
pulisher
Jul 07, 2025

Cantor Fitzgerald initiates Bioventus stock with Overweight rating on growth potential By Investing.com - Investing.com South Africa

Jul 07, 2025
pulisher
Jul 07, 2025

Cantor Fitzgerald initiates Bioventus stock with Overweight rating on growth potential - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 01, 2025

Cartilage Repair Regeneration Market is Going To Boom | Zimmer Biomet, Bioventus - newstrail.com

Jul 01, 2025
pulisher
Jun 23, 2025

Bioventus' Bold Bet on Core Markets: A Strategic Shift With High Stakes - AInvest

Jun 23, 2025
pulisher
Jun 19, 2025

BVS: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com

Jun 19, 2025
pulisher
Jun 19, 2025

(BVS) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 19, 2025
pulisher
Jun 14, 2025

Do Options Traders Know Something About Bioventus Stock We Don't? - The Globe and Mail

Jun 14, 2025
pulisher
Jun 06, 2025

(BVS) Proactive Strategies - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

Bone Growth Stimulator Market Booming Worldwide with - openPR.com

Jun 06, 2025

Bioventus Inc Azioni (BVS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$286.58
price down icon 0.03%
medical_devices STE
$227.25
price up icon 0.79%
medical_devices PHG
$25.84
price down icon 0.04%
$86.74
price up icon 0.36%
$76.77
price down icon 0.62%
medical_devices EW
$75.80
price down icon 1.44%
Capitalizzazione:     |  Volume (24 ore):